Comparison of Electrotherapy and intralesional injection of Glucantime in the treatment of Coetaneous Leishmaniasis
Phase 3
- Conditions
- Cutaneous Leishmaniasis.Cutaneous leishmaniasis
- Registration Number
- IRCT2016011822583N3
- Lead Sponsor
- Vice Chancellor for research of North Khorasan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
the lack of local or systemic treatment for Cutaneous Leishmaniasis; the appearance of skin lesions is less than 12 weeks ego.
Exclusion criteria: age less than 2 years; previous history of Cutaneous Leishmaniasis; pregnant or lactating women; malnutrition and underlying severe disease; contraindications for drug administration.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Size of lesion. Timepoint: Once a week. Method of measurement: Ruler.;Recovery time. Timepoint: Once a week. Method of measurement: Clinical observation.
- Secondary Outcome Measures
Name Time Method Inflammation. Timepoint: Once a week. Method of measurement: Clinical observation.;Blisters around the lesion. Timepoint: Once a week. Method of measurement: Clinical observation.;Secretion of the lesion. Timepoint: Once a week. Method of measurement: Clinical observation.